Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

414 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-L1 expression in papillary renal cell carcinoma.
Motoshima T, Komohara Y, Ma C, Dewi AK, Noguchi H, Yamada S, Nakayama T, Kitada S, Kawano Y, Takahashi W, Sugimoto M, Takeya M, Fujimoto N, Oda Y, Eto M. Motoshima T, et al. Among authors: takeya m. BMC Urol. 2017 Jan 13;17(1):8. doi: 10.1186/s12894-016-0195-x. BMC Urol. 2017. PMID: 28086852 Free PMC article.
The significance of TIMD4 expression in clear cell renal cell carcinoma.
Yano H, Motoshima T, Ma C, Pan C, Yamada S, Nakayama T, Kitada S, Fujimoto N, Kamba T, Takeya M, Komohara Y. Yano H, et al. Among authors: takeya m. Med Mol Morphol. 2017 Dec;50(4):220-226. doi: 10.1007/s00795-017-0164-9. Epub 2017 Jun 19. Med Mol Morphol. 2017. PMID: 28631038
The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas.
Komohara Y, Morita T, Annan DA, Horlad H, Ohnishi K, Yamada S, Nakayama T, Kitada S, Suzu S, Kinoshita I, Dosaka-Akita H, Akashi K, Takeya M, Jinushi M. Komohara Y, et al. Among authors: takeya m. Cancer Immunol Res. 2015 Sep;3(9):999-1007. doi: 10.1158/2326-6066.CIR-14-0156. Epub 2015 Mar 17. Cancer Immunol Res. 2015. PMID: 25783986
CXCL10 and CCL2 mRNA expression in monocytes is inversely correlated with the HLA-DR lower fraction of monocytes in patients with renal cell carcinoma.
Motoshima T, Komohara Y, Horlad H, Tsukamoto H, Fujita M, Saito Y, Tanoue K, Kasejima Y, Sugiyama Y, Kawano Y, Nishimura Y, Takeya M, Eto M. Motoshima T, et al. Among authors: takeya m. Oncol Lett. 2016 Mar;11(3):1911-1916. doi: 10.3892/ol.2016.4132. Epub 2016 Jan 20. Oncol Lett. 2016. PMID: 26998099 Free PMC article.
414 results